Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
en:start [2025/08/22 15:08] Gianluca Frustagli |
en:start [2025/12/02 19:30] (current) Gianluca Frustagli |
||
|---|---|---|---|
| Line 45: | Line 45: | ||
| > ☎ **+39 06 4990 3313** | > ☎ **+39 06 4990 3313** | ||
| + | \\ | ||
| ---- | ---- | ||
| \\ | \\ | ||
| Line 63: | Line 63: | ||
| <ifintranet> /* BEGIN OF INTRANET VERSION "NEWS" */ | <ifintranet> /* BEGIN OF INTRANET VERSION "NEWS" */ | ||
| - | <WRAP centeralign> | + | <WRAP group> /* Begin of row */ |
| + | <WRAP half column> /* Begin of column 1 */ | ||
| + | |||
| + | <wrap lo>Bari, November 17 - 19, 2025</wrap> | ||
| + | |||
| + | <wrap bigger hi>**First place at Magnethon 2025!**</wrap> | ||
| + | |||
| + | The team of researchers specialized in high-resolution nuclear magnetic resonance (NMR) spectroscopy at the Istituto Superiore di Sanità (ISS), composed of the HR-NMR units of FAST, the NMR Group of the CNCF, and the CN IATIS, has won first place overall in a prestigious international scientific competition called [[https://magnethon.com|Magnethon 2025]]. **[[en:eventi:2025:11:19:magnethon|[read more...]]]** | ||
| + | |||
| + | \\ | ||
| + | |||
| + | {{ :eventi:2025:11:19:magnethon-logo.png |Logo competizione Magnethon 2025}} | ||
| + | |||
| + | </WRAP> /* End of column 1 */ | ||
| + | <WRAP half column> /* Begin of column 2 */ | ||
| <wrap lo>October 23, 2024, Aula Marotta, 8:30 ~ 17:30</wrap> | <wrap lo>October 23, 2024, Aula Marotta, 8:30 ~ 17:30</wrap> | ||
| Line 73: | Line 88: | ||
| {{ :eventi:2024:10:23:ia-imaging-diag.jpeg?300 |AI/diagnostics subject fantasy banner}} | {{ :eventi:2024:10:23:ia-imaging-diag.jpeg?300 |AI/diagnostics subject fantasy banner}} | ||
| - | </WRAP> | ||
| + | </WRAP> /* End of column 2 */ | ||
| + | </WRAP> /* End of row */ | ||
| ---- | ---- | ||
| + | \\ | ||
| <WRAP group> /* Begin of row */ | <WRAP group> /* Begin of row */ | ||
| Line 237: | Line 254: | ||
| <wrap bigger>**GENEVAX Project**</wrap> | <wrap bigger>**GENEVAX Project**</wrap> | ||
| - | {{ :aree:fabiocell:genevax-loghi.png?350 |}} | + | {{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}} |
| - | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]] | + | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]] |
| Line 322: | Line 339: | ||
| <WRAP group> /* Begin of row */ | <WRAP group> /* Begin of row */ | ||
| <WRAP half column> /* Begin of column 1 */ | <WRAP half column> /* Begin of column 1 */ | ||
| - | |||
| - | |||
| - | <wrap lo>2018/11/07 10.00 am, Bovet room</wrap> \\ | ||
| - | <wrap bigger>[[eventi:|Presentation of the new Next Generation Sequencing services and the collaboration agreement with Bio-Fab Research]]</wrap> | ||
| - | |||
| - | |||
| - | </WRAP> /* End of column 1 */ | ||
| - | <WRAP half column> /* Begin of column 2 */ | ||
| Line 340: | Line 349: | ||
| - | </WRAP> /* End of row */ | + | </WRAP> /* End of column 1 */ |
| - | </WRAP> /* End of column 2 */ | + | <WRAP half column> /* Begin of column 2 */ |
| - | ---- | + | |
| - | \\ | + | |
| - | <WRAP group> /* Begin of row */ | + | |
| - | <WRAP half column> /* Begin of column 1 */ | + | |
| Line 355: | Line 360: | ||
| - | </WRAP> /* End of column 1 */ | + | </WRAP> /* End of row */ |
| - | <WRAP half column> /* Begin of column 2 */ | + | </WRAP> /* End of column 2 */ |
| + | ---- | ||
| + | \\ | ||
| + | |||
| + | <WRAP group> /* Begin of row */ | ||
| + | <WRAP half column> /* Begin of column 1 */ | ||
| Line 371: | Line 381: | ||
| - | </WRAP> /* End of column 2 */ | + | </WRAP> /* End of column 1 */ |
| - | </WRAP> /* End of row */ | + | <WRAP half column> /* Begin of column 2 */ |
| - | ---- | + | |
| - | \\ | + | |
| - | <WRAP group> /* Begin of row */ | + | |
| - | <WRAP half column> /* Begin of column 1 */ | + | |
| Line 387: | Line 393: | ||
| - | </WRAP> /* End of column 1 */ | + | </WRAP> /* End of column 2 */ |
| - | <WRAP half column> /* Begin of column 2 */ | + | </WRAP> /* End of row */ |
| + | ---- | ||
| + | \\ | ||
| + | |||
| + | <WRAP group> /* Begin of row */ | ||
| + | <WRAP half column> /* Begin of column 1 */ | ||
| Line 397: | Line 408: | ||
| {{ aree:calcolo:biostatistica:lucy-statistical_help.png?200 }} | {{ aree:calcolo:biostatistica:lucy-statistical_help.png?200 }} | ||
| + | |||
| + | |||
| + | </WRAP> /* End of column 1 */ | ||
| + | <WRAP half column> /* Begin of column 2 */ | ||
| + | |||
| + | |||
| + | /* BLANK */ | ||
| </WRAP> /* End of row */ | </WRAP> /* End of row */ | ||
| </WRAP> /* End of column 2 */ | </WRAP> /* End of column 2 */ | ||
| - | ---- | ||
| - | \\ | ||
| - | <WRAP group> /* Begin of row */ | ||
| - | <WRAP half column> /* Begin of column 1 */ | ||
| - | <wrap em>Presentation brochure of the FAST service</wrap> | + | </ifintranet> /********* END OF INTRANET VERSION "NEWS" *********/ |
| + | <ifinternet> /********* BEGIN OF INTERNET VERSION "NEWS" *********/ | ||
| - | [[en:brochure|{{ en:brochure-eng-v2-p1.png?nolink&190 }}]] | ||
| - | </WRAP> /* End of column 1 */ | + | <wrap lo>Bari, November 17 - 19, 2025</wrap> |
| - | <WRAP half column> /* Begin of column 2 */ | + | |
| - | /* EMPTY SPACE */ | + | <wrap bigger hi>**First place at Magnethon 2025!**</wrap> |
| - | </WRAP> /* End of column 2 */ | + | The team of researchers specialized in high-resolution nuclear magnetic resonance (NMR) spectroscopy at the Istituto Superiore di Sanità (ISS), composed of the HR-NMR units of FAST, the NMR Group of the CNCF, and the CN IATIS, has won first place overall in a prestigious international scientific competition called [[https://magnethon.com|Magnethon 2025]]. **[[en:eventi:2025:11:19:magnethon|[read more...]]]** |
| - | </WRAP> /* End of row */ | + | |
| + | {{ :eventi:2025:11:19:magnethon-logo.png?600 |Logo competizione Magnethon 2025}} | ||
| + | |||
| + | ---- | ||
| + | \\ | ||
| - | </ifintranet> /* END OF INTRANET VERSION "NEWS" */ | ||
| - | <ifinternet> /* BEGIN OF INTERNET VERSION "NEWS" */ | ||
| <WRAP group> /* Begin of row */ | <WRAP group> /* Begin of row */ | ||
| Line 592: | Line 606: | ||
| <wrap bigger>**GENEVAX Project**</wrap> | <wrap bigger>**GENEVAX Project**</wrap> | ||
| - | {{ :aree:fabiocell:genevax-loghi.png?350 |}} | + | {{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}} |
| - | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]] | + | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]] |
| Line 649: | Line 663: | ||
| ---- | ---- | ||
| \\ | \\ | ||
| + | |||
| + | |||
| <WRAP group> /* Begin of row */ | <WRAP group> /* Begin of row */ | ||
| <WRAP half column> /* Begin of column 1 */ | <WRAP half column> /* Begin of column 1 */ | ||
| - | |||
| - | |||
| - | <wrap lo>2018/11/07 10.00 am, Bovet room</wrap> \\ | ||
| - | <wrap bigger>[[eventi:|Presentation of the new Next Generation Sequencing services and the collaboration agreement with Bio-Fab Research]]</wrap> | ||
| - | |||
| - | |||
| - | </WRAP> /* End of column 1 */ | ||
| - | <WRAP half column> /* End of column 2 */ | ||
| - | |||
| <wrap lo>2018/09/21</wrap> \\ | <wrap lo>2018/09/21</wrap> \\ | ||
| Line 669: | Line 676: | ||
| - | </WRAP> /* End of column 2 */ | + | </WRAP> /* End of column 1 */ |
| - | </WRAP> /* End of row */ | + | <WRAP half column> /* Begin of column 2 */ |
| - | ---- | + | |
| - | \\ | + | |
| - | <WRAP group> /* Begin of row */ | + | |
| - | <WRAP half column> /* Begin of column 1 */ | + | |
| Line 687: | Line 690: | ||
| **Rossi room (Giano della Bella)** | **Rossi room (Giano della Bella)** | ||
| - | |||
| - | |||
| - | </WRAP> /* End of column 1 */ | ||
| - | <WRAP half column> /* Begin of column 2 */ | ||
| - | |||
| - | |||
| - | <wrap em>Presentation brochure of the FAST service</wrap> | ||
| - | |||
| - | [[en:brochure|{{ en:brochure-eng-v2-p1.png?nolink&190 }}]] | ||
| </WRAP> /* End of column 2 */ | </WRAP> /* End of column 2 */ | ||
| </WRAP> /* End of row */ | </WRAP> /* End of row */ | ||
| - | |||
| </ifinternet> /* END OF INTERNET VERSION "NEWS" */ | </ifinternet> /* END OF INTERNET VERSION "NEWS" */ | ||
| - | |||
